News
Oppenheimer Maintains Outperform on Seres Therapeutics, Lowers Price Target to $5
6 Mar 24
News, Price Target, Analyst Ratings
Emerson Electric To Rally More Than 19%? Here Are 10 Top Analyst Forecasts For Wednesday
6 Mar 24
News, Penny Stocks, Price Target, Small Cap, Pre-Market Outlook, Markets, Analyst Ratings, Trading Ideas
Chardan Capital Maintains Buy on Seres Therapeutics, Lowers Price Target to $8
6 Mar 24
News, Price Target, Analyst Ratings
Seres Therapeutics FY GAAP EPS $(0.89) Beats $(0.96) Estimate, Sales $126.33M Beat $126.07M Estimate
5 Mar 24
Earnings, News
Earnings Scheduled For March 5, 2024
5 Mar 24
Earnings
Seres Therapeutics's Earnings: A Preview
4 Mar 24
Earnings
Press releases
Seres Therapeutics Announces Completion of Patient Enrollment for SER-155 Phase 1B Cohort 2 Clinical Trial in Allogenic HSCT
9 Apr 24
Press Releases
Flagship Appoints Amy O'Shea as CEO-Partner and Chief Executive Officer of Invaio Sciences
8 Apr 24
Press Releases
Flagship Pioneering Named to Fast Company's Annual List of the World's Most Innovative Companies of 2024
19 Mar 24
Press Releases
Seres Therapeutics to Host Fourth Quarter 2023 Financial Results and Operational Progress Conference Call and Webcast on March 5, 2024
28 Feb 24
Press Releases
Seres Therapeutics to Participate in Cowen 44th Annual Healthcare Conference
27 Feb 24
Press Releases
Seres Therapeutics Announces the Appointment of Marella Thorell as Chief Financial Officer and the Retirement of David Arkowitz
26 Feb 24
Press Releases
Biotech With Potential: Coeptis Therapeutics (COEP) And 3 Underrated Gems
21 Feb 24